alphaflorosol lahus joogivees manustamiseks
alpha-vet kft. - florfenikool - lahus joogivees manustamiseks - 100mg 1ml 1000ml 1tk
alphafluben ravimsööda eelsegu
alpha-vet kft. - flubendasool - ravimsööda eelsegu - 50mg 1g 12kg 1tk
alphadoxan ravimsööda eelsegu
alpha-vet kft. - doksütsükliin - ravimsööda eelsegu - 100mg 1g 10000g 1tk
gefriderm nahasprei, lahus
alpha-vet kft. - prednisoloon+marbofloksatsiin+ketokonasool - nahasprei, lahus - 0,926mg+1,025mg+2,041mg 1ml 30ml 1tk
suiseng diff/a
laboratorios hipra, s.a. - clostridioides difficile toxoid a, clostridioides difficile toxoid b, clostridium perfringens, type a, alpha toxoid - immunologicals for suidae, inactivated bacterial vaccines for pigs, clostridium - sead - for the passive immunisation of neonatal piglets by means of the active immunisation of breeding sows and gilts:- to prevent mortality and reduce clinical signs and macroscopic lesions caused by clostridioides difficile toxins a and b. - to reduce clinical signs and macroscopic lesions caused by clostridium perfringens type a, alpha toxin.
alphafluben suukaudne geel
alpha-vet kft. - flubendasool - suukaudne geel - 44mg 1ml 7.5ml 1tk
filsuvez
amryt pharmaceuticals dac - dry extract from birch bark (der 5-10 : 1), extraction solvent n-heptane 95% (w/w) - epidermolysis bullosa dystrophica; epidermolysis bullosa, junctional - preparaadid haavade ja haavandite raviks - treatment of partial thickness wounds associated with dystrophic and junctional epidermolysis bullosa (eb) in patients 6 months and older.
alpha ject 5-3 süstelahus
pharmaq as - aeromonas vaktsiin+moritella vaktsiin+vibrio vaktsiin - süstelahus - 5000annus 1tk
alpha ject 3000 süsteemulsioon
pharmaq as - aeromonas vaktsiin+vibrio vaktsiin - süsteemulsioon - 1annus+1annus 0.1ml 500ml 1tk
apexxnar
pfizer europe ma eeig - pneumococcal polysaccharide serotype 1, pneumococcal polysaccharide serotype 3, pneumococcal polysaccharide serotype 4, pneumococcal polysaccharide serotype 5, pneumococcal polysaccharide serotype 6a, pneumococcal polysaccharide serotype 6b, pneumococcal polysaccharide serotype 7f, pneumococcal polysaccharide serotype 8, pneumococcal polysaccharide serotype 9v, pneumococcal polysaccharide serotype 10a, pneumococcal polysaccharide serotype 11a, pneumococcal polysaccharide serotype 12f, pneumococcal polysaccharide serotype 14, pneumococcal polysaccharide serotype 15b, pneumococcal polysaccharide serotype 18c, pneumococcal polysaccharide serotype 19a, pneumococcal polysaccharide serotype 19f, pneumococcal polysaccharide serotype 22f, pneumococcal polysaccharide serotype 23f, pneumococcal polysaccharide serotype 33f - pneumokoki infektsioonid - vaktsiinid - active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. vt lõigud 4. 4 ja 5. 1, mis käsitleb kaitset spetsiifiliste pneumokokkide serotüüpide eest. apexxnar should be used in accordance with official recommendations. .